Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 21, 2021 - Issue 1
Submit an article Journal homepage
1,063
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Is there value in using randomized placebo controlled trials in neuromuscular disease?

John R. Bacha Department of Physical Medicine and Rehabilitation, Rutgers University – New Jersey Medical School, Center for Ventilator Management Alternatives and Pulmonary Rehabilitation of the University Hospital of Newark, Newark, NJ, USACorrespondence[email protected]
View further author information
,
Giulio Chiarellob Department of Physical Medicine and Rehabilitation, Rutgers University – New Jersey Medical School, Newark, NJ, USAView further author information
,
William Weissc Pulmonary Division, Department of Medicine, Conamaugh Memorial Medical Center, Johnstown, PA, USAView further author information
&
Nizar Souayahd Department of Neurology, Rutgers University – New Jersey Medical School, Newark, NJ, USAView further author information
Pages 5-7 | Received 08 Jul 2020, Accepted 07 Oct 2020, Published online: 19 Oct 2020

References

  • Tzeng AC, Cheng JF, Fryczynski H, et al. A study of thyrotrophin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report. Am J Phys Med Rehabil. 2000;79:435–440.
  • Tuttle AH, Tohyama S, Ramsay T, et al. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain. 2015;156:2616–2626.
  • Avins AL, Cherkin DC, Sherman KJ, et al. Should we reconsider the routine use of placebo controls in clinical research? Trials. 2012;13:44.
  • Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn’t. 1996. Clin Orthop Relat Res. 2007;455:3–5.
  • Cook DJ, Guyatt GH, Laupacis A, et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992;102:305S–11S.
  • Bach JR. The Duchenne de Boulogne-Meryon controversy and pseudohypertrophic muscular dystrophy. J Hist Med Allied Sci. 2000;55:158–178.
  • Wootton D. Bad medicine. Oxford University Press; 2007.
  • Bach JR, Chiou M. Limitations of evidence-based medicine. Rev Port Pneumol. 2016;22:4–5.
  • Rose L, Adhikari NK, Leasa D, et al. Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation. Cochrane Database Syst Rev. 2017;1. Oxford University Press. DOI:10.1002/14651858.CD011833.pub2
  • Morrow B, Zampoli M, van Aswegen H, et al. Mechanical insufflation-exsufflation for people with neuromuscular disorders. Cochrane Database Syst Rev. 2013;12:CD011833. DOI:10.1002/14651858.CD011833.pub2.
  • Annane D, Orlikowski D, Chevret S. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev. 2014 Dec;13(12):CD001941.
  • Bach JR, Gonçalves MR, Hamdani I, et al. Extubation of unweanable patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137:1033–1039.
  • Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003;327(7429):1459–1461.
  • DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20–33.
  • Brill S Why medical bills are killing us. Time Magazine Special Report. 2013 Feb 20.
  • Harrison D, Mehta P, van Es MA, et al. “ALS reversals”: demographics, disease characteristics, treatments, and co-morbidities. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:495–499.
  • Patel S, Cuenant L, Bach JR. Respiratory management of spinal muscular atrophy. J Clin Neurol Neurosurg. 2019;2:119.
  • Bach JR, DeLisa JD. An alternative view on medical care delivery: a commentary. Am J Phys Med Rehabil. 2014;93:1095–1099.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.